思路迪医药股份(01244.HK) 公布,丁淦先生获委任为公司首席商务官,主要负责产品商业化相关工作。2021年至2024年,丁先生担任年衍药业(上海)和或然生物的首席执行官,主要负责公司的整体运作及管理。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-10 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.